Article
Prognostic Molecular Subtypes of Low-Grade Cancer of the Appendix
21 Dec 2015
Abstract excerpt
BACKGROUND: Appendiceal cancer (AC) patients treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) often demonstrate an unpredictable variability in their survival outcomes. Biomarkers predictive of CRS/HIPEC efficacy could better guide treatment decisions. We hypothesized that variation in the transcriptional programming of AC tumors might distinguish molecular subtypes...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
